non-small cell lung cancer

Label Expansion May Boost Revenues for AstraZeneca’s Tagrisso
Market Realist
Tue, 01/3/17 - 09:49 am
AstraZeneca
Tagrisso
non-small cell lung cancer
AstraZeneca’s Tagrisso Had a Strong Commercial Launch in 2016
Market Realist
Mon, 01/2/17 - 11:57 am
AstraZeneca
Tagrisso
non-small cell lung cancer
Merck kicks off lung-cancer campaign
Medical Marketing and Media
Sat, 12/10/16 - 10:32 am
Merck
Keytruda
DTC advertising
non-small cell lung cancer
AstraZeneca gives fuller picture of Tagrisso's edge in lung cancer
BioPharma Dive
Tue, 12/6/16 - 10:02 pm
AstraZeneca
Tagrisso
non-small cell lung cancer
FDA Grants Merck Priority Review for Keytruda Drug (MRK)
Investopedia
Mon, 11/28/16 - 09:56 am
FDA
priority review
Keytruda
Merck
non-small cell lung cancer
anti-PD-L1
Japan sets 50 pct price cut for Bristol Myers' Opdivo cancer drug
Yahoo/Reuters
Thu, 11/17/16 - 09:47 am
Japan
Bristol-Myers Squibb
Opdivo
drug pricing
non-small cell lung cancer
Ariad Pharma Rises on FDA Decision
Yahoo/24-7 Wall St
Mon, 10/31/16 - 09:37 am
Ariad Pharma
FDA
brigatinib
non-small cell lung cancer
Roche's lung cancer drug wins U.S. approval
Yahoo/Reuters
Tue, 10/18/16 - 10:27 pm
Roche
lung cancer
FDA
Tecentriq
non-small cell lung cancer
Novocure enrolls 1st patient in phase III brain metastases trial
Mass Device
Thu, 10/13/16 - 10:35 am
Novocure
devices
brain metastases
non-small cell lung cancer
3 Cancer Drugs That Could Get an FDA OK Next Year
Motley Fool
Mon, 10/10/16 - 09:02 am
FDA
rucaparib
Clovis Oncology
ovarian cancer
binimetinib
Array Biopharma
melanoma
brigatinib
Ariad Pharmaceuticals
non-small cell lung cancer
Novartis's Zykadia gets positive results, faces Roche pressure
Yahoo/Reuters
Fri, 09/23/16 - 10:07 pm
Novartis
Zykadia
Roche
non-small cell lung cancer
Novartis preps Zykadia for a frontline NSCLC pitch, but faces a tough rival in Roche; J&J, GSK hustle RA drug sirukumab to the FDA
Endpoints
Fri, 09/23/16 - 11:47 am
Novartis
Zykadia
non-small cell lung cancer
Roche
JNJ
GSK
rheumatoid arthritis
sirukumab
FDA accepts Merck & Co.'s Keytruda filing for first-line treatment of NSCLC, grants priority review
First Word Pharma
Wed, 09/7/16 - 10:13 am
Merck
FDA
Keytruda
non-small cell lung cancer
priority review
Roche's Tecentriq ready to compete in lung cancer
BioPharma Dive
Fri, 09/2/16 - 09:36 am
Roche
Tecentriq
non-small cell lung cancer
Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment
Yahoo/Benzinga
Thu, 09/1/16 - 09:23 am
Pfizer
Europe
Xalkori
non-small cell lung cancer
Will Bristol-Myers Squibb Co (BMY) Recover From Its Recent Slump?
Bidness, ETC
Mon, 08/15/16 - 09:46 pm
Bristol-Myers Squibb
Opdivo
Yervoy
non-small cell lung cancer
Will AstraZeneca plc Capture the Lung Cancer Market?
Bidness, ETC
Tue, 08/9/16 - 10:58 pm
AstraZeneca
non-small cell lung cancer
selumetinib
Now a two-time loser, AstraZeneca’s hopes for selumetinib dwindle after another PhIII flop
Endpoints
Tue, 08/9/16 - 11:36 am
AstraZeneca
selumetinib
non-small cell lung cancer
Why Merck’s Lung Cancer Success Won’t Last
Barron's
Tue, 08/9/16 - 10:39 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet
BioPharma Dive
Fri, 08/5/16 - 11:37 am
Bristol-Myers Squibb
Opdivo
Merck Keytruda
non-small cell lung cancer
PD-L1

Pages